Claims
- 1. A manual application of a topical clitoral sensitizing combination consisting essentially of L-arginine and a cooling agent comprised of Menthol and a 5-phosphodiaesterase inhibitor, wherein said combination is applicable manually to the clitoris.
- 2. The topical sensitizing combination as recited in claim 1, wherein said cooling agent includes peppermint oil.
- 3. The topical sensitizing combination as recited in claim 1, wherein said cooling agent includes cornmint oil.
- 4. The topical sensitizing combination as recited in claim 1, wherein said cooling agent includes Eucalypus oil.
- 5. The topical sensitizing combination as recited in claim 1, wherein said cooling agent includes Citronella oil.
- 6. The topical sensitizing combination as recited in claim 1, wherein said cooling agent includes Camphor oil.
- 7. The topical sensitizing combination as recited in claim 1, wherein said cooling agent includes Cinnamon oil.
- 8. The topical sensitizing combination as recited in claim 1, wherein said cooling agent essentially comprises peppermint oil.
- 9. The topical sensitizing combination as recited in claim 1, wherein said cooling agent essentially comprises cornmint oil.
- 10. The topical sensitizing combination as recited in claim 1, wherein said cooling agent essentially comprises Eucalyptus oil.
- 11. The topical sensitizing combination as recited in claim 1, wherein said cooling agent essentially comprises Citronella oil.
- 12. The topical sensitizing combination as recited in claim 1, wherein said cooling agent essentially comprises Camphor oil.
- 13. The topical sensitizing combination as recited in claim 1, wherein said cooling agent essentially comprises Cinnamon oil.
- 14. The topical sensitizing combination as recited in claim 1, wherein said combination contains less than 10% L-arginine.
- 15. The topical sensitizing combination as recited in claim 1, wherein said combination contains less than 10% menthol and said combination contains less than 10% L-arginine and said combination contains less than 10% 5-phosphodiaesterase inhibitor.
Parent Case Info
[0001] This application is a continuation-in-part application of co-pending U.S. patent application Ser. No. 10/731,692 filed 9 Dec. 2003 which is a divisional application of U.S. patent application Ser. No. 10/004,091, filed 23 Oct. 2001, now U.S. Pat. No. 6,702,733 issued 9 Mar. 2004, which is a continuation of application Ser. No. 09/520,110, filed 7 Mar. 2000, now U.S. Pat. No. 6,322,493 which is a continuation-in-part of application Ser. No. 09/469,959 filed on 21 Dec. 1999, which is a continuation-in-part of application Ser. No. 09/414,250, filed on 7 Oct. 1999, now U.S. Pat. No. 6,224,541 which is a continuation-in-part of application Ser. No. 09/340,227, filed on 1 Jul. 1999, now U.S. Pat. No. 6,179,775 each of which are incorporated herein by reference in their entirety.
Divisions (1)
|
Number |
Date |
Country |
Parent |
10004091 |
Oct 2001 |
US |
Child |
10731692 |
Dec 2003 |
US |
Continuations (1)
|
Number |
Date |
Country |
Parent |
09520110 |
Mar 2000 |
US |
Child |
10004091 |
Oct 2001 |
US |
Continuation in Parts (4)
|
Number |
Date |
Country |
Parent |
10731692 |
Dec 2003 |
US |
Child |
10803148 |
Mar 2004 |
US |
Parent |
09469959 |
Dec 1999 |
US |
Child |
09520110 |
Mar 2000 |
US |
Parent |
09414250 |
Oct 1999 |
US |
Child |
09469959 |
Dec 1999 |
US |
Parent |
09340227 |
Jul 1999 |
US |
Child |
09414250 |
Oct 1999 |
US |